http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017139210-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7268cbb4eb4749f87e239c51ca55f3e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26d27eccef24fc734bf9d44f4cb9ca8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26a4c1bea420e268d22e72ca733e0d40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0519bb50440cb37bd46d0b7336f6e1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2beefb16eb3d0e28c4f0ea1206e66ca9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ee6a9559f160a617ba87674185702e7 |
| publicationDate | 2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017139210-A1 |
| titleOfInvention | C5-c6-oxacylic fused iminothiadiazine dioxide compounds bearing an ether linker as bace inhibitors, compositions, and their use |
| abstract | In its many embodiments, the present invention provides certain C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker, including compounds Formula (I): or a tautomer thereof, and pharmaceutically acceptable salts of said compounds and said tautomers, wherein R N , R 1 , R 2 , R A , ring A, ring C, and m are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed. |
| priorityDate | 2016-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 611.